Your selections:
- van Hummel, Annika, Taleski, Goce, Sontag, Jean-Marie, Feiten, Astrid Feentje, Ke, Yazi D., Ittner, Lars M., Sontag, Estelle
- Panicker, Nikita, Coutman, Melody, Lawlor-O'Neill, Charley, Kahl, Richard G. S., Roselli, Severine, Verrills, Nicole M.
Protein phosphatase 2A (PP2A): a key phosphatase in the progression of chronic obstructive pulmonary disease (COPD) to lung cancer
- Nader, Cassandra P., Cidem, Aylin, Verrills, Nicole M., Ammit, Alaina J.
Protein phosphatase 2A: more than a passenger in the regulation of epithelial cell-cell junctions
- Schuhmacher, Diana, Sontag, Jean-Marie, Sontag, Estelle
The functional role of PPP2R2A in luminal breast cancer
The role of protein phosphatase 2A in Alzheimer’s disease pathogenesis
TRAIL signals through the ubiquitin ligase MID1 to promote pulmonary fibrosis
- Collison, Adam M., Li, Junyao, de Siqueira, Ana Pereira, Lv, Xuejiao, Toop, Hamish D., Morris, Jonathan C., Starkey, Malcolm R., Hansbro, Philip M., Zhang, Jie, Mattes, Joerg
Protein phosphatase 2A and tau: an orchestrated 'Pas de Deux'
- Taleski, Goce, Sontag, Estelle
Functional importance of PP2A regulatory subunit loss in breast cancer
- Watt, Lauren F., Panicker, Nikita, Mannan, Abdul, Copeland, Ben, Kahl, Richard G. S., Dun, Matthew D., Young, Barbara, Roselli, Severine, Verrills, Nicole M.
- Hoffman, Alexander, Taleski, Goce, Sontag, Estelle
Activation of protein phosphatase 2A in FLT3+ acute myeloid leukemia cells enhances the cytotoxicity of FLT3 tyrosine kinase inhibitors
- Smith, Amanda M., Dun, Matthew D., Toop, Hamish, Lock, Richard B., Powell, Jason A., Thomas, Daniel, Guthridge, Mark A., Moore, Andrew, Ashman, Leonie K., Skelding, Kathryn A., Enjeti, Anoop, Verrills, Nicole M., Lee, Erwin M., Harrison, Celeste, Kahl, Richard, Flanagan, Hayley, Panicker, Nikita, Mashkani, Baratali, Don, Anthony S., Morris, Jonathan
Immunoregulatory therapies for inflammatory diseases
- Rahman, Md. Mostafizur, Prabhala, Pavan, Rumzhum, Nowshin N., Patel, Brijeshkumar S., Wickop, Thomas, Hansbro, Phillip M., Verrills, Nicole M., Ammit, Alaina J.
- Sokulsky, Leon A., Collison, Adam M., Nightingale, Scott, Le Fevre, Anna, Percival, Elizabeth, Starkey, Malcolm R., Hansbro, Philip M., Foster, Paul S., Mattes, Joerg
Basal protein phosphatase 2A activity restrains cytokine expression: role for MAPKs and tristetraprolin
- Rahman, Md. Mostafizur, Rumzhum, Nowshin N., Morris, Jonathan C., Clark, Andrew R., Verrills, Nicole M., Ammit, Alaina J.
Altered protein phosphatase 2A methylation and Tau phosphorylation in the young and aged brain of methylenetetrahydrofolate reductase (MTHFR) deficient mice
- Sontag, Jean-Marie, Wasek, Brandi, Taleski, Goce, Smith, Josephine, Arning, Erland, Sontag, Estelle, Bottiglieri, T
Targeting PP2A activation as a novel therapeutic strategy for receptor tyrosine kinase driven leukaemia
- Sontag, Jean-Marie, Nunbhakdi-Craig, Viyada, Sontag, Estelle
PP2A phosphatase suppresses function of the mesenchymal invasion regulator NEDD9
- Bradbury, Peta, Mahmassani, Maha, Zhong, Jessie, Turner, Kylie, Paul, Andre, Verrills, Nicole M., O'Neill, Geraldine M.
Suppression of PP2A is critical for protection of melanoma cells upon endoplasmic reticulum stress
- Tay, K. H., Jin, L., Zhang, X. D., Tseng, H. - Y., Jiang, C. C., Ye, Y., Thorne, R. F., Liu, T., Guo, S. T., Verrills, N. M., Hersey, P.
Are you sure you would like to clear your session, including search history and login status?